glp-1 nz RNZ - Pharmac has received two applications to fund Wegovy or semaglutide - a receptor agonist for weight loss. ⬇ Read more below New Zealand Anaesthesia | iHeart

Additionally, using a weighted blanket can provide gentle pressure, helping to relieve restlessness and improve sleep quality

Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial

With the advent of these new drugs, it is likely that our specialty will see these patients and they may ask why there is this risk

They are not FDA-approved for type 1 diabetes

Of interest, poor glycemic control alters the interaction between innate and adaptive immune response with the subsequent promotion of infectious/inflammatory processes and viral replication, as in SARS-CoV-2 infection (Villarreal-Caldern et al